BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9485186)

  • 1. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B.
    Häusler P; Papoff G; Eramo A; Reif K; Cantrell DA; Ruberti G
    Eur J Immunol; 1998 Jan; 28(1):57-69. PubMed ID: 9485186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
    Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
    J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP).
    Suhara T; Mano T; Oliveira BE; Walsh K
    Circ Res; 2001 Jul; 89(1):13-9. PubMed ID: 11440972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism.
    Wright K; Kolios G; Westwick J; Ward SG
    J Biol Chem; 1999 Jun; 274(24):17193-201. PubMed ID: 10358077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
    Bai RY; Ouyang T; Miething C; Morris SW; Peschel C; Duyster J
    Blood; 2000 Dec; 96(13):4319-27. PubMed ID: 11110708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.
    Thakkar H; Chen X; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    J Biol Chem; 2001 Oct; 276(42):38361-9. PubMed ID: 11461904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of susceptibility to Fas-mediated apoptosis in HL-60 cells through down-regulation of cellular FLICE-inhibitory protein by phosphatidylinositol 3-kinase inhibitors.
    Kondo G; Iwase M; Watanabe H; Uchida M; Takaoka S; Ohashi M; Ito D; Nagumo M
    Oncol Rep; 2005 Nov; 14(5):1215-22. PubMed ID: 16211288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis.
    Murray JT; Craggs G; Wilson L; Kellie S
    Inflamm Res; 2000 Nov; 49(11):610-8. PubMed ID: 11131301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury.
    Hu Z; Sayeed MM
    Am J Physiol Cell Physiol; 2005 May; 288(5):C1171-8. PubMed ID: 15625305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor-induced PKB/Akt activity is sustained by phosphoinositide 3-kinase dependent and independent signals in sympathetic neurons.
    Virdee K; Xue L; Hemmings BA; Goemans C; Heumann R; Tolkovsky AM
    Brain Res; 1999 Aug; 837(1-2):127-42. PubMed ID: 10433995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.
    Crowder RJ; Freeman RS
    J Neurosci; 1998 Apr; 18(8):2933-43. PubMed ID: 9526010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase.
    Genot EM; Arrieumerlou C; Ku G; Burgering BM; Weiss A; Kramer IM
    Mol Cell Biol; 2000 Aug; 20(15):5469-78. PubMed ID: 10891487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
    Madge LA; Pober JS
    J Biol Chem; 2000 May; 275(20):15458-65. PubMed ID: 10748004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
    Salh B; Wagey R; Marotta A; Tao JS; Pelech S
    J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells.
    Eder AM; Dominguez L; Franke TF; Ashwell JD
    J Biol Chem; 1998 Oct; 273(43):28025-31. PubMed ID: 9774418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt.
    Wang D; Sul HS
    J Biol Chem; 1998 Sep; 273(39):25420-6. PubMed ID: 9738010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.